SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950123-97-002843
Filing Date
1997-03-31
Accepted
1997-03-31 00:00:00
Documents
13
Period of Report
1996-12-31
SROs
NYSE

Document Format Files

Seq Description Document Type Size
1 JOHNSON & JOHNSON 10-K405 47394
2 CERTIFICATE OF AMENDMENT EX-3.A.III 3738
3 1995 STOCK OPTION PLAN EX-10.A 6995
4 EXECUTIVE INCENTIVE PLAN EX-10.F 12393
5 DEFERRED FEE PLAN FOR DIRECTORS EX-10.G 16600
6 DEFERRED FEE PLAN EX-10.H 14503
7 EXECUTIVE INCOME DEFERRAL PLAN EX-10.I 19072
8 EXCESS SAVINGS PLAN EX-10.J 24043
9 CALCULATION OF EARNINGS PER SHARE EX-11 3655
10 STATEMENT OF COMPUTATION OF RATIO OF EARNINGS EX-12 3355
11 ANNUAL REPORT EX-13 151536
12 SUBSIDIARIES EX-21 20639
13 FINANCIAL DATA SCHEDULE EX-27 2025
  Complete submission text file 0000950123-97-002843.txt   328513
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 9085240400
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 001-03215 | Film No.: 97570528
SIC: 2834 Pharmaceutical Preparations